Australis Reports Q3 2021 Results
The period under review, Fiscal Q3 2021, relates to the period ended December 31, 2020.
- The period under review, Fiscal Q3 2021, relates to the period ended December 31, 2020.
- Results reported therefore relate predominantly to the legacy business and do not include any financials related to the proposed ALPS and Green Therapeutics LLC ("GT" or "Green Therapeutics") acquisitions (see press releases dated January 5, 2021, February 9, 2021 and February 24, 2021).
- The financial results for Q3 2021 concern the period ended December 31, 2020.
- Management will host a conference call discussing the results and the go forward business on March 2, 2021 at10AM EST.